Effect of Reparel Knee Sleeve With Knee Injection
Study Details
Study Description
Brief Summary
The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a belief that anti-inflammatory sleeve technology may be beneficial in treating knee OA. The purpose of this study is to determine if the Reparelâ„¢ knee sleeve results in superior mobility, functionality, and pain outcomes as compared to a placebo knee sleeve in managing knee OA.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Patients who are recommended non-operative management of their knee osteoarthritis and have consented to participate in the study will be randomized into two groups to receive either of the following
-
Reparel knee sleeve
-
Placebo knee sleeve
Participants assigned to both groups will be given instructions on how to use/wear the sleeve while performing activities of daily living or sports that had previously resulted in knee pain and also be asked to do the follows:
-
Wear the sleeve as much as they possibly can
-
Not change their usual activities and diet during the time they are on this study.
-
Record in a diary the number of hours sleeve was worn per day
-
Record any adverse effects or discomfort due to sleeve use.
-
Not to receive any injections in the subsequent 6 months following baseline randomization visit.
Participant background information that is relevant to this study will also be collected from their medical record including age, sex, and race and stored in a hospital secure computer database (REDCap).
Participants will also be asked to complete the Knee Injury and Osteoarthritis Outcome Score (KOOS), Single Assessment Numeric Evaluation (SANE), Oxford Knee Score (OKS), Lysholm Score, UCLA Activity Score and Visual Analog Scale (VAS) survey questionnaires at baseline randomization visit (T0), at 4 weeks (T1), at 3 months (T2), and at 6 months (T3) to assess the mobility, functionality, and pain associated with the affected leg.
The responses to the surveys will be recorded on a password-protected laptop and all patient identifiers will be replaced with unique identifier numbers. Only the study team will have access to the responses from the forms. The analysis of de-identified data will be done through SPSS 27, and scores for the questionnaires will be averaged and compared between the two groups.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Reparel Sleeve Group Reparel sleeve and corticosteroid injection |
Device: Reparel knee sleeve
Unlabelled thermo-active knee sleeve that improves bloodflow to knee and decreased pain
Drug: Corticosteroid injection
intraarticular knee injection of betamethasone and bupivacaine 0.5% (dose is determined by joint size)
Other Names:
|
Placebo Comparator: Placebo Sleeve Group Placebo sleeve and corticosteroid injection |
Drug: Corticosteroid injection
intraarticular knee injection of betamethasone and bupivacaine 0.5% (dose is determined by joint size)
Other Names:
Device: Placebo knee sleeve
unlabeled compression knee sleeve
|
Outcome Measures
Primary Outcome Measures
- Change in University of California, Los Angeles (UCLA) Activity Score at 4 weeks [4 weeks (T1)]
activity score, 1-10, 10 is best outcome
- Change in University of California, Los Angeles (UCLA) Activity Score at 3 months [3 months (T2)]
activity score, 1-10, 10 is best outcome
- Change in University of California, Los Angeles (UCLA) Activity Score at 6 months [6 months (T3)]
activity score, 1-10, 10 is best outcome
- Change in Lysholm Score at 4 weeks [4 weeks (T1)]
ability to manage activities of daily living, 0-100, 100 is best outcome
- Change in Lysholm Score at 3 months [3 months (T2)]
ability to manage activities of daily living, 0-100, 100 is best outcome
- Change in Lysholm Score at 6 months [6 months (T3)]
ability to manage activities of daily living, 0-100, 100 is best outcome
- Change in Oxford Knee Score (OKS) at 4 weeks [4 weeks (T1)]
knee pain and function score, 0-48, 48 is best outcome
- Change in Oxford Knee Score (OKS) at 3 months [3 months (T2)]
knee pain and function score, 0-48, 48 is best outcome
- Change in Oxford Knee Score (OKS) at 6 months [6 months (T3)]
knee pain and function score, 0-48, 48 is best outcome
- Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 4 weeks [4 weeks (T1)]
knee pain and function score, 0-100, 100 is best outcome
- Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 3 months [3 months (T2)]
knee pain and function score, 0-100, 100 is best outcome
- Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 months [6 months (T3)]
knee pain and function score, 0-100, 100 is best outcome
- Change in Single Assessment Numeric Evaluation (SANE) at 4 weeks [4 weeks (T1)]
function score, 0-100%, 100% is best outcome
- Change in Single Assessment Numeric Evaluation (SANE) at 3 months [3 months (T2)]
function score, 0-100%, 100% is best outcome
- Change in Single Assessment Numeric Evaluation (SANE) at 6 months [6 months (T3)]
function score, 0-100%, 100% is best outcome
- Change in Visual Analog Scale (VAS) at 4 weeks [4 weeks (T1)]
pain score, 0-10, 10 is best outcome
- Change in Visual Analog Scale (VAS) at 3 months [3 months (T2)]
pain score, 0-10, 10 is best outcome
- Change in Visual Analog Scale (VAS) at 6 months [6 months (T3)]
pain score, 0-10, 10 is best outcome
Secondary Outcome Measures
- Satisfaction with knee sleeve at 4 weeks [4 weeks (T1)]
0-10, 10 is best
- Satisfaction with knee sleeve at 3 months [3 months (T2)]
0-10, 10 is best
- Satisfaction with knee sleeve at 6 months [6 months (T3)]
0-10, 10 is best
- Average wear time of sleeve over past week at 4 weeks [4 weeks (T1)]
0-24 hours, 24 hours is best
- Average wear time of sleeve over past week at 3 months [3 months (T2)]
0-24 hours, 24 hours is best
- Average wear time of sleeve over past week at 6 months [6 months (T3)]
0-24 hours, 24 hours is best
Eligibility Criteria
Criteria
Inclusion Criteria:
-
osteoarthritis visible on knee radiograph
-
patient opting for non-surgical treatment
Exclusion Criteria:
-
bilateral symptomatic knee osteoarthritis
-
prior surgery on the knee of interest
-
hardware present on the knee of interest
-
gross instability detected on physical exam
-
malignancy in the knee of question
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UAB Hospital Highlands | Birmingham | Alabama | United States | 35205 |
Sponsors and Collaborators
- University of Alabama at Birmingham
Investigators
- Principal Investigator: Amit Momaya, MD, University of Alabama at Birmingham
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB-300006118